Bayer's pharma, consumer sales suffer in Q3 as it works to close Monsanto deal
admin 26th October 2017 Uncategorised 0Some analysts and market watchers worried about Bayer’s focus when the drugmaker went after agrochem giant Monsanto in a $66 billion deal last year, and now the company’s third-quarter results are sparking more concern.
More: Bayer's pharma, consumer sales suffer in Q3 as it works to close Monsanto deal
Source: fierce